ECSP982538A - PHARMACEUTICAL FORMULATIONS CONTAINING VARICONAZOLE - Google Patents

PHARMACEUTICAL FORMULATIONS CONTAINING VARICONAZOLE

Info

Publication number
ECSP982538A
ECSP982538A ECSP982538A ECSP982538A EC SP982538 A ECSP982538 A EC SP982538A EC SP982538 A ECSP982538 A EC SP982538A EC SP982538 A ECSP982538 A EC SP982538A
Authority
EC
Ecuador
Prior art keywords
variconazole
pharmaceutical formulations
formulations containing
4so3h
pharmaceutically acceptable
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Valerie Denise Harding
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42043458&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP982538(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Priority to ECSP982538 priority Critical patent/ECSP982538A/en
Publication of ECSP982538A publication Critical patent/ECSP982538A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La invención proporciona una formulación farmacéutica que comprende variconazol, o un derivado farmacéuticamente aceptable del mismo, y un derivado de ciclodextrina de fórmula I, (gráfico) en la que R1a-g, R2a-g y R3a-g representan independientemente OH o O(CH2)4SO3H; siempre que al menos uno de los R1 a-g represente O(CH2)4SO3H; o una sal farmacéuticamente aceptable del mismo.The invention provides a pharmaceutical formulation comprising variconazole, or a pharmaceutically acceptable derivative thereof, and a cyclodextrin derivative of formula I, (graph) in which R1a-g, R2a-g and R3a-g independently represent OH or O ( CH2) 4SO3H; provided that at least one of R1 a-g represents O (CH2) 4SO3H; or a pharmaceutically acceptable salt thereof.

ECSP982538 1998-06-16 1998-06-16 PHARMACEUTICAL FORMULATIONS CONTAINING VARICONAZOLE ECSP982538A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP982538 ECSP982538A (en) 1998-06-16 1998-06-16 PHARMACEUTICAL FORMULATIONS CONTAINING VARICONAZOLE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP982538 ECSP982538A (en) 1998-06-16 1998-06-16 PHARMACEUTICAL FORMULATIONS CONTAINING VARICONAZOLE

Publications (1)

Publication Number Publication Date
ECSP982538A true ECSP982538A (en) 1999-01-26

Family

ID=42043458

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP982538 ECSP982538A (en) 1998-06-16 1998-06-16 PHARMACEUTICAL FORMULATIONS CONTAINING VARICONAZOLE

Country Status (1)

Country Link
EC (1) ECSP982538A (en)

Similar Documents

Publication Publication Date Title
PA8453201A1 (en) PHARMACEUTICAL FORMULATIONS CONTAINING VORICONAZOLE
TR199901077A2 (en) �spen�iyari form�lasyonlar.
DK0994710T3 (en) Pharmaceutical compositions for oral administration comprising a benzhydrylpiperazine and a cyclodextrin
AR066982A2 (en) HETEROAROMATIC COMPOUNDS REPLACED AS INHIBIDORESS TIROSIN QUINASA, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE IN THE PREPARATION OF MEDICINES
DK0960107T3 (en) 6-Thiosubstituted paclitaxels
CY1112687T1 (en) METHOD FOR USING DICTIONARIES AND COMPOSITIONS THAT INCLUDE
DE60030741D1 (en) CHINAZOLINE COMPOUNDS AS A REMEDY
MX9204625A (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF A MAMMAL SPECIES, WHICH SUFFERS FROM CONGESTIVE HEART DEFICIENCY.
UY27329A1 (en) SHAMPOOS WITH BEHENYL ALCOHOL
BR0109943A (en) Pharmaceutical Compositions
BR0215184A (en) orally active taxane derivative pharmaceutical compositions having increased bioavailability
IT1318649B1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF MUCOSITES AND STOMATITIS.
GT199800101A (en) SOLID PHARMACEUTICAL COMPOSITION CONTAINING A DERIVATIVE OF BENZOFURANE.
ES2083668T5 (en) ANTIVIRICAL COMBINATIONS CONTAINING NUCLEOSIDE ANALOGS.
IL94460A0 (en) Pharmaceutical compositions containing imipramine or derivatives thereof
SE0102843D0 (en) Stabilized oral pharmaceutical composition containing lodide and lodate and method
AR020563A1 (en) TIA-ALQUINOIC COMPOUNDS (POLI) AND THEIR DERIVATIVES, COMPOSITIONS THAT INCLUDE THEM AND THEIR USE
ES2177024T3 (en) EMPLOYMENT OF THE FANQUINOMA FOR THE TREATMENT OF ALZHEIMER'S DISEASE.
IT1318401B1 (en) N-DESACETYLTHIOCOLCHYCIN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS WHICH CONTAIN.
DE60214476D1 (en) Pharmaceutical preparations containing active ingredients which are suitable for unauthorized administration
EP1051141A4 (en) INSULIN CONTAINING PHARMACEUTICAL COMPOSITIONS CONTAINING AN AMYLINAGONIST
ES2182524T3 (en) COMPOSITIONS OF HYDROXYOMEPRAZOL AND ITS USES.
GT199800086A (en) PHARMACEUTICAL FORMULATIONS CONTAINING VORICONAZOLE.
AR008474A1 (en) DERIVATIVE OF 9-DIHYDROERYTHROMYCIN A 6.9; 11,12-DICICLOCARBONATO, PHARMACEUTICAL COMPOSITION AND BACTERICIDE PREPARATION THAT CONTAIN IT AND ITS USE
AR004382A1 (en) PEPTIDOS, ITS OBTAINING AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.